Larvol Veri

NTRK1 fusion NTRK1 fusion	Spindle Cell Sarcoma Spindle Cell Sarcoma	entrectinib Sensitive: C1 - Off-label entrectinib Sensitive : C1
NTRK3 fusion NTRK3 fusion	Spindle Cell Sarcoma Spindle Cell Sarcoma	entrectinib Sensitive: C1 - Off-label entrectinib Sensitive : C1
KRAS G12V KRAS G12V	Spindle Cell Sarcoma Spindle Cell Sarcoma	BAL3833 Sensitive: C3 – Early Trials BAL3833 Sensitive : C3
SMARCB1 negative SMARCB1 negative	Spindle Cell Sarcoma Spindle Cell Sarcoma	tazemetostat Sensitive: C3 – Early Trials tazemetostat Sensitive : C3
TPM3-NTRK1 fusion TPM3-NTRK1 fusion	Spindle Cell Sarcoma Spindle Cell Sarcoma	larotrectinib Sensitive: C4 – Case Studies larotrectinib Sensitive : C4
KIAA1549-BRAF fusion + PTEN deletion KIAA1549-BRAF fusion + PTEN deletion	Spindle Cell Sarcoma Spindle Cell Sarcoma	bevacizumab + sorafenib + temsirolimus Sensitive: C4 – Case Studies bevacizumab + sorafenib + temsirolimus Sensitive : C4

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and